VIP Receptors – Page 2 – Purification and characterization of miRNA Inhibitor

Clawson, Deborah Ann Myers, and Sara Feldman; the protection monitoring committee of Michael Benatar, Sally Greenberg, Henry Kaminski, Rup Tandan, and Gil Wolfe; and Cytokinetics, Inc

By eagulf April 10, 2022VIP Receptors

Clawson, Deborah Ann Myers, and Sara Feldman; the protection monitoring committee of Michael Benatar, Sally Greenberg, Henry Kaminski, Rup Tandan, and Gil Wolfe; and Cytokinetics, Inc., helping Pemetrexed disodium personnel…

It demonstrated advantages and revealed the feasibility of replacing scFvs by nanobodies in generating bispecific CAR-T cells

By eagulf February 18, 2022VIP Receptors

It demonstrated advantages and revealed the feasibility of replacing scFvs by nanobodies in generating bispecific CAR-T cells. Open in a separate window Figure 3 The application of VHH in advanced…

All experiments were repeated at least two times

By eagulf February 2, 2022VIP Receptors

All experiments were repeated at least two times. tissue but was constitutively overexpressed by isocitrate dehydrogenase (IDH) wild-type major LGGs and GBMs in the mesenchymal subgroup and recurrent tumors. Compact…

Clawson, Deborah Ann Myers, and Sara Feldman; the protection monitoring committee of Michael Benatar, Sally Greenberg, Henry Kaminski, Rup Tandan, and Gil Wolfe; and Cytokinetics, Inc

It demonstrated advantages and revealed the feasibility of replacing scFvs by nanobodies in generating bispecific CAR-T cells

All experiments were repeated at least two times

Archives

Categories